Publication Cover
Experimental Aging Research
An International Journal Devoted to the Scientific Study of the Aging Process
Volume 47, 2021 - Issue 1
845
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Polypharmacy, Physical and Nutritional Status, and Depression in the Elderly: Do Polypharmacy Deserve Some Credits in These Problems?

, , , , , , & show all
Pages 79-91 | Received 18 Oct 2019, Accepted 02 Nov 2020, Published online: 12 Nov 2020

References

  • Agostini, J. V., Han, L., & Tinetti, M. E. (2004). The relationship between number of medications and weight loss or impaired balance in older adults. Journal of the American Geriatrics Society, 52(10), 1719–1723. doi:10.1111/j.1532-5415.2004.52467.x
  • Bahat, G., Tufan, F., Bahat, Z., Aydin, Y., Tufan, A., Akpinar, T. S., … Karan, M. A. (2013). Assessments of functional status, comorbidities, polypharmacy, nutritional status and sarcopenia in Turkish community-dwelling male elderly. The Aging Male, 16(2), 67–72. doi:10.3109/13685538.2013.771329
  • Bonaga, B., Sánchez-Jurado, P. M., Martínez-Reig, M., Ariza, G., Rodríguez-Mañas, L., Gnjidic, D., … Abizanda, P. (2018). Frailty, polypharmacy, and health outcomes in older adults: The frailty and dependence in albacete study. Journal of the American Medical Directors Association, 19(1), 46–52. doi:10.1016/j.jamda.2017.07.008
  • Bouillon, K., Kivimaki, M., Hamer, M., Sabia, S., Fransson, E. I., Singh-Manoux, A., … Batty, G. D. (2013). Measures of frailty in population-based studies: An overview. BMC Geriatrics, 13(1). doi:10.1186/1471-2318-13-64
  • Brunner, E., & Puri, M. L. (2001). Nonparametric methods in factorial designs. Statistical Papers, 42(1), 1–52.
  • Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987). A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. Journal of Chronic Diseases, 40(5), 373–383. doi:10.1016/0021-9681(87)90171-8
  • Choi, Eun Hi, and Jeong Yeol Seo. (2009). U-health for management of chronic diseases-physical activity and theraupetic exercises. Journal of the Korean Medical Association, 52 (12), 1154–1163.
  • De Groot, V., Beckerman, H., Lankhorst, G. J., & Bouter, L. M. (2003). How to measure comorbidity: A critical review of available methods. Journal of Clinical Epidemiology, 56(3), 221–229.
  • Eyigor, S., & Kutsal, Y. (2012). Polypharmacy in the elderly: To prescribe, or not prescribe “That is the question”. Turkish Journal of Geriatrics/Türk Geriatri Dergisi, 15(4), 445–454.
  • Eyigor, S., Kutsal, Y. G., Duran, E., Huner, B., Paker, N., Durmus, B., … Ceceli, E. (2015). Frailty prevalence and related factors in the older adult—FrailTURK project. AGE, 37(3). doi:10.1007/s11357-015-9791-z
  • Fried, T. R., O’Leary, J., Towle, V., Goldstein, M. K., Trentalange, M., & Martin, D. K. (2014). Health outcomes associated with polypharmacy in community-dwelling older adults: A systematic review. Journal of the American Geriatrics Society, 62(12), 2261–2272. doi:10.1111/jgs.13153
  • George, C., & Verghese, J. (2017). Polypharmacy and gait performance in community-dwelling older adults. Journal of the American Geriatrics Society, 65(9), 2082–2087. doi:10.1111/jgs.14957
  • Griep, M. I., Mets, T. F., Collys, K., Ponjaert-Kristoffersen, I., & Massart, D. L. (2000). Risk of malnutrition in retirement homes elderly persons measured by the “mini-nutritional assessment”. Journals of Gerontology. Series A: Biological Sciences and Medical Sciences, 55(2), M57–M63.
  • Hall, S. F., Groome, P. A., Streiner, D. L., & Rochon, P. A. (2006). Interrater reliability of measurements of comorbid illness should be reported. Journal of Clinical Epidemiology, 59(9), 926–933.
  • Hann, D., Winter, K., & Jacobsen, P. (1999). Measurement of depressive symptoms in cancer patients: Evaluation of the center for epidemiological studies depression scale (CES-D). Journal of Psychosomatic Research, 46(5), 437–443.
  • Heuberger, R. A., & Caudell, K. (2011). Polypharmacy and nutritional status in older adults. Drugs and Aging, 28(4), 315–323. doi:10.2165/11587670-000000000-00000
  • Holden, M. K., Gill, K. M., & Magliozzi, M. R. (1986). Gait assessment for neurologically impaired patients. Physical Therapy, 66(10), 1530–1539. doi:10.1093/ptj/66.10.1530
  • Ivanova, I., Wauters, M., Stichele, R. V., Christiaens, T., De Wolf, J., Dilles, T., & Elseviers, M. (2018). Medication use in a cohort of newly admitted nursing home residents (Ageing@NH) in relation to evolving physical and mental health. Archives of Gerontology and Geriatrics, 75, 202–208. doi:10.1016/j.archger.2018.01.005
  • Jyrkkä, J., Enlund, H., Lavikainen, P., Sulkava, R., & Hartikainen, S. (2011). Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three-year period in an elderly population. Pharmacoepidemiology and Drug Safety, 20(5), 514–522. doi:10.1002/pds.2116
  • Khezrian, M., McNeil, C. J., Myint, P. K., & Murray, A. D. (2018). The association between polypharmacy and late life deficits in cognitive, physical and emotional capability: A cohort study. International Journal of Clinical Pharmacy, 41(1), 251–257. doi:10.1007/s11096-018-0761-2
  • Linjakumpu, T., Hartikainen, S., Klaukka, T., Veijola, J., Kivelä, S.-L., & Isoaho, R. (2002). Use of medications and polypharmacy are increasing among the elderly. Journal of Clinical Epidemiology, 55(8), 809–817. doi:10.1016/s0895-4356(02)00411-0
  • Maher, R. L., Hanlon, J., & Hajjar, E. R. (2013). Clinical consequences of polypharmacy in elderly. Expert Opinion on Drug Safety, 13(1), 57–65. doi:10.1517/14740338.2013.827660
  • Morandi, A., Bellelli, G., Vasilevskis, E. E., Turco, R., Guerini, F., Torpilliesi, T., … Trabucchi, M. (2013). Predictors of rehospitalization among elderly patients admitted to a rehabilitation hospital: The role of polypharmacy, functional status, and length of stay. Journal of the American Medical Directors Association, 14(10), 761–767. doi:10.1016/j.jamda.2013.03.013
  • Ong, Gao-Jing, et al. (2017). Clinician agreement and influence of medication-related characteristics on assessment of polypharmacy. Pharmacology Research Perspectives,5 (3), e00321.
  • Pamoukdjian, F., Aparicio, T., Zelek, L., Boubaya, M., Caillet, P., François, V., … Paillaud, E. (2017). Impaired mobility, depressed mood, cognitive impairment and polypharmacy are independently associated with disability in older cancer outpatients: The prospective physical frailty in elderly cancer patients (PF-EC) cohort study. Journal of Geriatric Oncology, 8(3), 190–195. doi:10.1016/j.jgo.2017.02.003
  • Peron, E. P., Gray, S. L., & Hanlon, J. T. (2011). Medication use and functional status decline in older adults: A narrative review. The American Journal of Geriatric Pharmacotherapy, 9(6), 378–391. doi:10.1016/j.amjopharm.2011.10.002
  • Pugh, M. J. V., Palmer, R. F., Parchman, M. L., Mortensen, E., Markides, K., & Espino, D. V. (2007). Association of suboptimal prescribing and change in lower extremity physical function over time. Gerontology, 53(6), 445–453. doi:10.1159/000119460
  • Radloff, L. S. (1977). The CES-D Scale. Applied Psychological Measurement, 1(3), 385–401. doi:10.1177/014662167700100306
  • Rawle, M. J., Cooper, R., Kuh, D., & Richards, M. (2018). Associations between polypharmacy and cognitive and physical capability: A British birth cohort study. Journal of the American Geriatrics Society, 66(5), 916–923. doi:10.1111/jgs.15317
  • Santilli, V. (2014). Clinical definition of sarcopenia. Clinical Cases in Mineral and Bone Metabolism. doi:10.11138/ccmbm/2014.11.3.177
  • Sarikaya, D., Halil, M., Kuyumcu, M. E., Kilic, M. K., Yesil, Y., Kara, O., … Yavuz, B. B. (2015). Mini nutritional assessment test long and short form are valid screening tools in Turkish older adults. Archives of Gerontology and Geriatrics, 61(1), 56–60.
  • Sganga, F., Vetrano, D. L., Volpato, S., Cherubini, A., Ruggiero, C., Corsonello, A., … Onder, G. (2014). Physical performance measures and polypharmacy among hospitalized older adults: Results from the crime study. The Journal of Nutrition, Health & Aging, 18(6), 616–621. doi:10.1007/s12603-014-0029-z
  • Stel, V. S., Smit, J. H., Pluijm, S. M. F., & Lips, P. (2003). Consequences of falling in older men and women and risk factors for health service use and functional decline. Age and Ageing, 33(1), 58–65. doi:10.1093/ageing/afh028
  • Tanigor Goksel and Sibel Eyigor. (2020). Evaluation of dysphagia in patients with sarcopenia in a rehabilitation setting: insights from the vicious cycle. European Geriatric Medicine,1–8.
  • Tatar, A., & Saltukoglu, G. (2010). The adaptation of the CES-depression scale into Turkish through the use of confirmatory factor analysis and item response theory and the examination of psychometric characteristics. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology, 20(3), 213–227.
  • Turner, Justin P., et al. (2016). Polypharmacy cut- points in older people with cancer: How many medications are too many? Supportive Care in Cancer, 24(4), 1831–1840.
  • Vellas, B., Guigoz, Y., Garry, P. J., Nourhashemi, F., Bennahum, D., Lauque, S., & Albarede, J.-L. (1999). The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition, 15(2), 116–122. doi:10.1016/s0899-9007(98)00171-3
  • Vetrano, D. L., Villani, E. R., Grande, G., Giovannini, S., Cipriani, M. C., Manes-Gravina, E., … Onder, G. (2018). Association of polypharmacy with 1-year trajectories of cognitive and physical function in nursing home residents: Results from a multicenter european study. Journal of the American Medical Directors Association, 19(8), 710–713. doi:10.1016/j.jamda.2018.04.008
  • Volaklis, K. A., Thorand, B., Peters, A., Halle, M., Heier, M., Strasser, B., … Meisinger, C. (2017). Physical activity, muscular strength, and polypharmacy among older multimorbid persons: Results from the KORA-Age study. Scandinavian Journal of Medicine and Science in Sports, 28(2), 604–612. doi:10.1111/sms.12884
  • Wang, R., Chen, L., Fan, L., Gao, D., Liang, Z., He, J., … Gao, L. (2015). Incidence and effects of polypharmacy on clinical outcome among patients aged 80+: A five-year follow-up study. PloS One, 10(11), e0142123. doi:10.1371/journal.pone.0142123
  • Wastesson, J. W., Morin, L., Tan, E. C. K., & Johnell, K. (2018). An update on the clinical consequences of polypharmacy in older adults: A narrative review. Expert Opinion on Drug Safety, 17(12), 1185–1196. doi:10.1080/14740338.2018.1546841
  • Wilson, N. M., Hilmer, S. N., March, L. M., Cameron, I. D., Lord, S. R., Seibel, M. J., & Sambrook, P. N. (2010). Associations between drug burden index and physical function in older people in residential aged care facilities. Age and Ageing, 39(4), 503–507. doi:10.1093/ageing/afq053

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.